SELLAS Life Sciences Group, Inc. — Director's Dealing 2012

Jun 19, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2012-06-15

Reporting Person: MAZANET ROSEMARY (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-15	Stock Option (right to buy)	$1.73	A	150000	Acquired	2022-04-13	Common Stock (150000)	Direct

Footnotes

F1: The option grant was approved by the Issuer's Board of Directors on April 13, 2012, subject to stockholder approval of an amendment to the Amended and Restated 2007 Incentive Plan of the Issuer (the "Plan") to increase the number of shares of common stock available under the Plan. The Issuer's stockholders approved such amendment on June 15, 2012.

F2: Option vests in 16 equal quarterly installments beginning three months from April 13, 2012.